Evotec SE
$9.81
24H
Market Cap
Volume
Supply
Price Chart
About Evotec SE - EVT.F
EVOTEC SE is a drug discovery and development company that collaborates with pharmaceutical and biotechnology firms to develop therapeutics, leveraging a platform that covers all aspects of drug research and development from early-stage discovery to late-stage clinical trials. Based in Hamburg, Germany, the company operates globally, offering a wide range of services and partnering models, including fee-for-service, alliances, and joint ventures.
What are Evotec SE's core values and mission statement?
EVOTEC SE's core values revolve around innovation, collaboration, and excellence in drug discovery and development. Their mission is to discover and develop highly effective treatments for diseases with significant unmet medical needs through partnerships and leading-edge research platforms.
Who founded Evotec SE and when?
EVOTEC SE was founded by a group of scientists including Dr. Karsten Henco, Dr. Ulrich Aldag, Dr. Rainer Guth, Dr. Cord Dohrmann, and Dr. Manfred Eigen in 1993.
Who leads Evotec SE?
EVOTEC SE is led by Dr. Werner Lanthaler, who serves as the Chief Executive Officer.
Where is Evotec SE located, and what is its base country?
EVOTEC SE is headquartered in Hamburg, Germany.
On which exchanges is Evotec SE traded?
EVOTEC SE is traded on the Frankfurt Stock Exchange under the ticker symbol EVT and on the OTC Markets in the United States under the ticker symbol EVTCY.
Historical data
Evotec SE (EVT) Price Live Data
The live price of Evotec SE (EVT) is $9.81, with a trading volume of 26,370 in the last 24 hours. Wrapstocks updates the EVT price in real-time. Evotec SE is down -3.63% in the last 24 hours. The company has a live market cap of $1,737,778,330.27 and a supply of 177,186,009 EVT stocks.
Evotec SE (EVT) is traded on Frankfurt Stock Exchange, and currently, the market is closed; trading will be resumed in 14 hours and 24 minutes.
